Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
12 2021
Historique:
revised: 20 09 2021
received: 01 06 2021
accepted: 03 10 2021
pubmed: 10 10 2021
medline: 27 1 2022
entrez: 9 10 2021
Statut: ppublish

Résumé

Outcomes of kidney transplantation (KT) after controlled circulatory death (cDCD) with highly expanded criteria donors (ECD) and recipients have not been thoroughly evaluated. We analyzed in a multicenter cohort of 1161 consecutive KT, granular baseline donor and recipient factors predicting transplant outcomes, selected by bootstrapping and Cox proportional hazards, and were validated in a contemporaneous European KT cohort (n = 1585). 74.3% were DBD and 25.7% cDCD-KT. ECD-KT showed the poorest graft survival rates, irrespective of cDCD or DBD (log-rank < 0.001). Besides standard ECD classification, dialysis vintage, older age, and previous cardiovascular recipient events together with low class-II-HLA match, long cold ischemia time and combining a diabetic donor with a cDCD predicted graft loss (C-Index 0.715, 95% CI 0.675-0.755). External validation showed good prediction accuracy (C-Index 0.697, 95%CI 0.643-0.741). Recipient older age, male gender, dialysis vintage, previous cardiovascular events, and receiving a cDCD independently predicted patient death. Benefit/risk assessment of undergoing KT was compared with concurrent waitlisted candidates, and despite the fact that undergoing KT outperformed remaining waitlisted, remarkably high mortality rates were predicted if KT was undertaken under the worst risk-prediction model. Strategies to increase the donor pool, including cDCD transplants with highly expanded donor and recipient candidates, should be performed with caution.

Identifiants

pubmed: 34626501
doi: 10.1111/tri.14131
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2494-2506

Informations de copyright

© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Références

Maggiore U, Oberbauer R, Pascual J, et al. Strategies to increase the donor pool and access to kidney transplantation: an international perspective. Nephrol Dial Transplant 2015; 30: 217.
Pérez-Sáez MJ, Montero N, Redondo-Pachón D, Crespo M, Pascual J. Strategies for an expanded use of kidneys from elderly donors. Transplantation 2017; 101: 727.
Summers DM, Johnson RJ, Allen J, et al. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet (London, England) 2010; 376: 1303.
Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant 2007; 7: 1797.
Summers DM, Johnson RJ, Hudson A, Collett D, Watson CJ, Bradley JA. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. Lancet (London, England) 2013; 381: 727.
Yu S, Long JJ, Yu Y, et al. Survival benefit of accepting kidneys from older donation after cardiac death donors. Am J Transplant 2021; 21: 1138.
Peters-Sengers H, Berger SP, Heemskerk MBA, et al. Stretching the limits of renal transplantation in elderly recipients of grafts from elderly deceased donors. J Am Soc Nephrol 2017; 28: 621.
Lorent M, Foucher Y, Kerleau K, et al. The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research. BMC Nephrol 2019; 20: 365.
Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
Rao PS, Ojo A. The alphabet soup of kidney transplantation: SCD, DCD, ECD-fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol 2009; 4: 1827.
Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. J Clin Epidemiol 2015; 68: 134.
Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009; 88: 231.
Pérez-Só MJ, Lafuente Covarrubias O, Herná/tcgqndez D, et al. Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study). BMC Nephrol 2019; 20: 233.
Favi E, Puliatti C, Iesari S, Monaco A, Ferraresso M, Cacciola R. Impact of donor age on clinical outcomes of primary single kidney transplantation from maastricht category-iii donors after circulatory death. Transplant Direct 2018; 4: e396.
Nagaraja P, Roberts GW, Stephens M, et al. Impact of expanded criteria variables on outcomes of kidney transplantation from donors after cardiac death. Transplantation 2015; 99: 226.
Arcos E, José Pérez-Sáez M, Comas J, Lloveras J, Tort J, Pascual J. Assessing the limits in kidney transplantation: use of extremely elderly donors and outcomes in elderly recipients. Transplantation 2020; 104: 176.
Lomero M, Gardiner D, Coll E, et al. Donation after circulatory death today: an updated overview of the European landscape. Transpl Int 2020; 33: 76.
Organ Donation and Transplantation Activities. 2017 Report. Available at: http://www.transplant-observatory.org/download/2017-activity-data-report/. Accessed June 14, 2020.
Sammut IA, Burton K, Balogun E, et al. Time-dependent impairment of mitochondrial function after storage and transplantation of rabbit kidneys. Transplantation 2000; 69: 1265.
Peters-Sengers H, Houtzager JHE, Idu MM, et al. Impact of cold ischemia time on outcomes of deceased donor kidney transplantation: an analysis of a national registry. Transplant Direct 2019; 5: e448.
Kayler L, Yu X, Cortes C, Lubetzky M, Friedmann P. Impact of cold ischemia time in kidney transplants from donation after circulatory death donors. Transplant Direct 2017; 3: e177.
Pérez-Sáez MJ, Arcos E, Comas J, Crespo M, Lloveras J, Pascual J. Survival benefit from kidney transplantation using kidneys from deceased donors aged ≥75 years: a time-dependent analysis. Am J Transplant 2016; 16: 2724.
Moreso F, Seron D, Gil-Vernet S, et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999; 14: 930.
Liapis H, Gaut JP, Klein C, et al. Banff histopathological consensus criteria for preimplantation kidney biopsies. Am J Transplant 2017; 17: 140.
Wang CJ, Wetmore JB, Crary GS, Kasiske BL. The donor kidney biopsy and its implications in predicting graft outcomes: a systematic review. Am J Transplant 2015; 15: 1903.
Jadlowiec CC, Heilman RL, Smith ML, et al. Transplanting kidneys from donation after cardiac death donors with acute kidney injury. Am J Transplant 2020; 20: 864.
Lia D, Singer P, Nair V, Yang J, Teperman L, Grodstein E. DCD Renal Transplantation from donors with Acute Kidney Injury. Transplantation 2021; 105: 886.

Auteurs

Nuria Montero (N)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Néstor Toapanta (N)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.

Natàlia Pallarès (N)

Biostatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.

Marta Crespo (M)

Kidney Transplant Unit, Nephrology Department, Hospital del Mar, Barcelona, Spain.

Fritz Diekmann (F)

Kidney Transplant Unit, Nephrology Department, Hospital Clínic Provincial, Institut d'Investigació Biomèdica August Pi i Sunyer, RedInRen, Barcelona, Spain.

Lluis Guirado (L)

Kidney Transplant Unit, Nephrology Department, Fundació Puigvert, Barcelona, Spain.

Rafael Esteban (R)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Sergi Codina (S)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Edoardo Melilli (E)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Anna Buxeda (A)

Kidney Transplant Unit, Nephrology Department, Hospital del Mar, Barcelona, Spain.

Gonzalo Velis (G)

Kidney Transplant Unit, Nephrology Department, Hospital del Mar, Barcelona, Spain.

Irina B Torres (IB)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.

Ignacio Revuelta (I)

Kidney Transplant Unit, Nephrology Department, Hospital Clínic Provincial, Institut d'Investigació Biomèdica August Pi i Sunyer, RedInRen, Barcelona, Spain.

Alicia Molina Andujar (A)

Kidney Transplant Unit, Nephrology Department, Hospital Clínic Provincial, Institut d'Investigació Biomèdica August Pi i Sunyer, RedInRen, Barcelona, Spain.

Carme Facundo (C)

Kidney Transplant Unit, Nephrology Department, Fundació Puigvert, Barcelona, Spain.

Beatriz Bardají (B)

Kidney Transplant Unit, Nephrology Department, Fundació Puigvert, Barcelona, Spain.

Lluís Riera (L)

Urology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Maria Fiol (M)

Urology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Josep M Cruzado (JM)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Jordi Comas (J)

Catalan Organ Transplant Organization, Barcelona, Spain.

Magali Giral (M)

CRTI UMR 1064, Inserm, Université de Nantes, ITUN, CHU Nantes, RTRS Centaure, Nantes, France.

Maarten Naesens (M)

Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.

Anders Åsberg (A)

Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Department of Pharmacy, University of Oslo, Oslo, Norway.

Francesc Moreso (F)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.

Oriol Bestard (O)

Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH